Odonate Therapeutics
Ryan Cole is currently the Vice President of Operations at Odonate Therapeutics. Prior to this, they worked as a Senior Financial Analyst for Mergers & Acquisitions at Thermo Fisher Scientific from May 2012 to February 2014. Before that, they were a Senior in Assurance & Advisory Services at Ernst & Young from September 2009 to May 2012.
After completing their undergraduate studies in accounting and finance at Santa Clara University, Ryan Cole pursued a career in accounting and finance, eventually becoming a Certified Public Accountant (inactive) through the California State Board of Accountancy.
Ryan Cole reports to Kevin C. Tang, Chairman & CEO. Ryan Cole works with Thomas Wei - Chief Scientific Officer, Tracey McKennon - Vice President of Quality Assurance, and Jennifer Schroeder - Vice President of Program Management and Technology.
This person is not in any offices
Odonate Therapeutics
Odonate Therapeutics is dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer